CIK: 1763581 - Address: 400 Alexander Park Drive, Princeton, NJ 08540
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/20/24 16:38
3/18/24
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS-16914.050-12-8139D
2/5/24 21:15
2/1/24
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.a-6015.780-4-2151D
2/2/24 19:07
1/31/24
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.00075151D
2/2/24 19:07
1/31/24
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-6015.740-4-2151D
2/2/23 13:02
1/31/23
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.00043149D
2/2/23 13:02
1/31/23
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-1910.120-2-1149D
1/23/23 19:10
1/20/23
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d6135.000123512147D
11/2/22 16:31
10/31/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.0001224D
11/2/22 16:31
10/31/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-311.8500-124D
8/25/22 15:25
7/31/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.0001224D
8/25/22 15:25
8/1/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-27.8100-124D
5/3/22 17:19
4/30/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.0001223D
5/3/22 17:19
4/30/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-26.6200-123D
2/2/22 16:33
1/31/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.00031223D
2/2/22 16:33
1/31/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-107.580-1-623D
1/28/22 16:29
1/26/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.0000122D
1/28/22 16:29
1/26/22
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-18.0900022D
11/19/21 15:05
11/18/21
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeP213.1000122D
11/2/21 15:45
10/31/21
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.0001222D
11/2/21 15:45
11/1/21
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-417.1600-122D
10/28/21 14:04
10/26/21
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeM.d00.0000122D
10/28/21 14:04
10/27/21
URGNUrogen Pharma Ltd.L3HealthDrugPharmaceutical PreparationsSchoenberg MarkNJOChief MeS.d-216.3200022D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact